Collegium Pharmaceutical

Founded in Stoughton, Massachusetts, Collegium Pharmaceutical is dedicated to developing and commercializing prescription drugs aimed at treating central nervous system (CNS), respiratory, and skin disorders. The company's core mission is to improve the lives of individuals with serious medical conditions through a portfolio of differentiated medications. Collegium Pharmaceutical leverages best-in-class science to create meaningful medicines that contribute to healthier people and stronger communities.

Notable affiliated individuals and investors include key figures in the pharmaceutical industry, although specific names are not provided. Collegium Pharmaceutical has achieved significant milestones in drug development and commercialization, establishing itself as a leading specialty pharmaceutical company. Its impact is reflected in its commitment to addressing serious medical conditions and supporting healthcare professionals with innovative treatments.